ELCC 2016: Differences in expression of predictive biomarkers between primary and metastatic NSCLC - 102017

Spotlight
Video

ELCC 2016: Differences in expression of predictive biomarkers between primary and metastatic NSCLC

VJOncology has 632 videos Subscribe Here

Loading........
Description: At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 13–16 April 2016, Zoran Gatalica, MD, DSc, from Caris Life Sciences, Phoenix, AZ, discusses a study evaluating the differences in expression of multiple biomarkers of targeted biological therapies, immune checkpoint inhibitors and chemotherapeutic agents between primary and metastatic tumors in patients with non-small cell lung cancer (NSCLC).
Shared By : VJOncology
Posted on : 05/04/16
Added : 2 years ago